James Strachan

Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at.

From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.

Content by James Strachan:

 Outside the Lab Professional development

Ten Year Views: With Graham Cooks

| James Strachan | 6 min read

Graham Cooks discusses the decade’s most exciting developments, where he thinks the field will take us next, and some personal highlights
Tools & Techniques Analytical science

The Truth’s in the Tooth

| James Strachan | 3 min read

Detecting biomarkers of fetal alcohol spectrum disorder in naturally shed baby teeth opens the door to diagnosis

Questioning “The Science”

| James Strachan | 2 min read

What would it mean for science as a whole if the results of a seminal Alzheimer's paper underpinning the amyloid hypothesis were fabricated?
Tools & Techniques Analytical science

A Picture Paints a Thousand… New Therapies?

| James Strachan | 3 min read

How AI-enabled tools can democratize cell painting to speed up drug discovery and reduce failure rates
Tools & Techniques Analytical science

Breath Analysis with a (Very) Fine Toothed Comb

| James Strachan

JILA scientists improve the sensitivity of their frequency comb breathalyzer to disease biomarkers by a thousandfold

Tools & Techniques Analytical science

The Cortex-Characterizing Consortium

| James Strachan

Findings from 17 studies show that the primary motor cortex has up to 116 different types of cells
Research Field Drug discovery

Unleashing Cellular Potential

| James Strachan

Mogrify's Karin Schmitt explains how epigenetic switches are support the conversion and maintenance of any clinically valuable cell types
Research Field Cancer

“Curing Cancer? That’s Cute”

| James Strachan

Cell and gene therapies are now considered mainstream therapeutic modalities – with revolutionary potential. But that hasn’t always been the case…
Research Field Cell & gene therapy

Perusing the Pipeline

| James Strachan

With cell and gene therapies being all the rage, we take a peek at some of the advanced therapies coming down the pipe.
Outside the Lab Professional development

Revolutionizing Medicine – While Learning “Novartian”

| James Strachan

Sitting Down With... Bruce Levine, Professor in Cancer Gene Therapy, Perelman School of Medicine, University of Pennsylvania.
Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register

October Issue of The Translational Scientist